Racial variation in lung cancer

Anticancer Research

Volumn 17, Issue 4 A, 1997, Pages 2843-2848

  Groeger, A M ^a,c   Odocha, O ^b   Mueller, M R ^a   Salat, A ^c   Mallinger, R ^a   Baumgartner, S ^c   Wolner, E ^a   Kaiser, H E ^a,d  

^a UNIVERSITY OF VIENNA   (Austria)

^b HOWARD UNIVERSITY HOSPITAL   (United States)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Lung neoplasms; Occupational carcinogens; Race; Sex

Indexed keywords

ADULT; AGE; AGED; ARTICLE; AUSTRIA; CANCER SURVIVAL; CAUCASIAN; FEMALE; GENDER; GENE DISRUPTION; GENE FUNCTION; GENOTOXICITY; HUMAN; INCIDENCE; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; RACE; RISK FACTOR; TUMOR LOCALIZATION; UNITED STATES; UNIVERSITY HOSPITAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AUSTRIA; CARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; COHORT STUDIES; CONTINENTAL POPULATION GROUPS; DISTRICT OF COLUMBIA; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 0030856955     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Ries LAQ, Miller BA, Hankey BF: SEER Cancer Statistics review, 1973-1991: National Cancer Institute. Nih Pub No 94-2789, Bethesda, Md, 263, 1994.
2. Becher H, Jedrychowski W, Wahrendorf J, Basa-Cierpialck Z, Flak E, Gomola K: Effect of occupational air pollutants on various histological types of lung cancer: a population based case-control study. Br J Ind Med 50(2): 136-142, 1993.
3. Forastiere F, Perucci CA, Arca M, Axelson O: Indirect estimates of lung cancer death rates in Italy not attributable to active smoking. Epidemiology 4(6): 502-510, 1993.
4. Saccomanno G, Auerbach O, Kuschner M, Harley NH, Michels RY, Anderson MW, Bechtel JJ: A comparison between the localization of lung tumors in uranium miners and in nonminers from 1947 to 1991. Cancer 77(7): 1278-1283, 1996.
5. Muscat JE, Stcllman SD, Wynder EL: Insulation, asbestos, smoking habits, and lung cancer cell types. Am J Ind Med 27(2): 257-269, 1995.
6. Swanson GM, Lin CS, Burns PB: Diversity in the association between occupation and lung cancer among black and white men. Cancer Epidemiol Biomarkers Prev 2(4): 313-320, 1993.
7. Waldum HL, Nilsen OG, Nilsen T, Rorvik H, Syversen V, Sanvik AK, Haugen OA, Torp SH, Brenna E: Long-term effects of inhaled nicotine. Life Sci 58(16): 1339-1346, 1996.
8. Takase H: Specificity of plasma peroxidized low density lipoprotein in lung cancer. Nippon Kyobu Shikkan Gakkai Zasshi 33(5): 520-527, 1995.
9. Van Wersch JW: The behaviour of lipoprotein(a) in patients with various diseases. Scand J Clin Lab Invest 54(7): 559-562, 1994.
10. Reeve JG, Morgan J, Clark PM, Blechen NM: Insulin-like growth factor and IGF binding protein in growth hormone dysreguhition and abnormal glucose tolerance in small cell lung cancer patients. Eur J Cancer 31A(9): 1455-1460, 1995.
11. Sato Y, Marutsuka K, Asada Y, Yamada M, Setoguchi T, Sumiyoshi A: Pulmonary tumor thrombotic microangiopathy. Pathol Int 45(6): 436-440, 1995.
12. Tian Y, Gebitekin C, Martin P, Satur CM, Mearns A, Walker DR: Influence of heparin thromboprophylaxis on plasma leucocyte elastase levels following lobectomy for lung carcinoma. Blood Coagul Fibrinolysis 6(6): 527-530, 1995.
13. Gabazza EC, Taguchi O, Yamakami T, Machishi M, Ibata H, Suzuki S: Evaluating prethrombotic state in lung cancer usine molecular markers. Chest 103(1): 196-200, 1993.
14. Matsushima K: Properties of interleukin 8 and its correlation with inflammatory diseases and malignant neoplasia. Gan To Kagaku Ryoho 21(14): 2525-2532, 1994.
15. Singh B, Greenbaum E, Cole R: Carbon-laden macrophages in pleural fluid of crack smokers. Diagn Cytopathol 13(4): 316-319, 1995.
16. Nagao K, Suzuki A, Yuguchi Y, Yamagishi F, Shimura A, Kuriyama T: Recent advances in imaging in diagnosis and treatment of tuberculosis. Kekkaku 69(2): 91-96, 1994.
17. Ousehal A, Essadki O, Abdelouafi A, Kadiri R: Superior vena cava thrombosis. Radiological aspects. Apropos of 28 cases. Ann Radiol (Paris) 36(4): 303-309, 1993.
18. Hartmann A, Blaszyk H, McGovern RM, Schroeder JJ, Cunningham J, De Vries EM, Kovach JS, Sommer SS: P53 gene mutations inside and outside of exon 5-8: the patterns differ in breast and other cancers. Oncogene 10(4): 681-688, 1995.
19. Crofts F, Taioli E, Trachman J, Cosma GN, Currie D, Toniolo P, Garte SJ: Functional significance of different human CYP1A1 genotypes. Carcinogenesis 15(12): 2961-2963, 1994,
20. Sugimura H, Suzuki I, Hamada GS, Iwase T, Takahashi T, Nagura K, Iwata H, Watanabe S, Kino I, Tsugane S: Cytochrome P450 1A1 genotype in lung cancer patients and controls in Rio de Janeiro, Brazil. Cancer Epidemiol Biomarkers Prev 3(7): 145-148, 1994.
21. Shields PG, Caporaso N, Falk RT, Sugimura H, Trivers GE, Trump BF, Hoover RN, Weston A, Harris CC: Lung cancer, race, and CYP1A1 genetic polymorphism. Cancer Epidemiol Biomarkers Prev 2(5): 481-485, 1993.
22. Kelsey KT, Wiencke JK, Spitz MR: A race-specific genetic polymorphism in the CYP1A1 gene is not associated with lung cancer in African Americans. Carcinogenesis 15(6): 1121-1124, 1994.
23. London SJ, Daly AK, Fairbrother KS, Holmes C, Carpenter CL, Navidi WC, Idle JR: Lung cancer risk in African-Americans in relation to a race-specific CYP1A1 polymorphism. Cancer Res 55(24): 6035-6037, 1995.
24. Keller JE, Hosve HL: Risk factors for lung cancer among nonsmoking Illinois residents. Environ Res 60(1): 1-11, 1993.
25. Klemm PR: Variables influencing psychosocial adjustment in lung cancer: a preliminary study. Oncol Nurs Forum 21(6): 1059-1062, 1994.
26. Akerley WL, Moritz TE, Ryan LS, Henderson WG, Zacharski LR: Racial comparison of outcomes of male Department of Veterans Affairs patients with lung and colon cancer. Arch Intern Med 153(14): 1681-1688, 1993.
27. Devesa SS, Grauman DJ, Blot WJ: Recent cancer patterns among men and women in the United States: clues for occupational research. J Occup Med 36(8): 832-841, 1994.
28. London SJ, Daly AK, Cooper J, Navidi WC, Carpenter CL, Idle JR: Polymorphism of glutathione S-transferase Ml and lung cancer risk among African-Americans and Caucasians in Los Angeles County, CA. J Natl Cancer Inst 87(16): 1246-1253, 1995.
29. Shaw GL, Falk RT, Deslauriers J, Frame JN, Nesbitt JC, Pass HI, Issaq HJ, Hoover RN, Tucker MA: Debrisoquine metabolism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 4(1): 41-48, 1995.
30. Sugerman JR, Dennis LK, White E: Cancer survival among American Indians in western Washington State. Cancer Causes Control 5(5): 440-448, 1994.
31. Tefre T, Daly AK, Armstrong M, Leathart JB, Idle JR, Brogger A, Borresen AL: Genotyping of the CYP2DG6 gene in Norwegian lung cancer patients and controls. Pharmacogenetics 4(2): 47-57, 1994.
32. Weston A, Ling-Cawley HM, Caporaso NE, Bowman ED, Hoover RN, Trump BF, Harris CC: Determination of allelic frequencies of L-myc and a p53 polymorphism in human lung cancer. Carcinogenesis 15(4): 583-587, 1994.
33. Jin X, Wu X, Roth JA, Amos CI, King TM, Branch C, Honn SE, Spitz MR: Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis 26(9): 2205-2208, 1995.
34. Lyn D, Cherney BW, Lalande M, Berenson JR, Lichtenstein A, Lupold S, Bhatia KG, Smulson M: A duplicated region is responsible for the poly(ADP-ribose) polymerase polymorphism, on chromosome 13, associated with a predisposition to cancer. Am J Hum Genet 52(1): 124-134, 1995.
35. Rotimi C, Austin H, Delzell E, Day C, Macaluso M, Honda Y: Retrospective follow-up study of foundry and engine plant workers. Am J Ind Med 24(4): 485-489, 1993.
36. Spitz MR, Hsu TC, Wu X, Fueger JJ, Amos CI, Roth JA: Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev 4(2): 99-103, 1995.
37. Strom SS, Wu S, Sigurdson AJ, Hsu TC, Fueger JJ, Lopez J, Tee PG, Spitz MR: Lung cancer, smoking patterns, and mutagen sensitivity in Mexican-Americans. J Natl Cancer Inst Monogr 18: 29-33, 1995.
38. Taioli E, Crofts F, Trachman J, Demopoulos R, Toniolo P, Garte SJ: A specific African-American CYP1A1 polymorphism is associated with adenocarcinoma of the lung. Cancer Res 55(3): 472-473, 1995.
39. Wu X, Hsu TC, Annegers JF, Amos C, Fueger JJ, Spitz MR: A casecontrol study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer cases. Cancer Res 55(3): 557-561, 1995.
40. Wu X, Delclos GL, Annegers JF, Bondy ML, Honn SE, Henry B, Hsu TC, Spitz MR: A case-control study of wood dust exposure, mutagen sensitivity, and lung cancer risk. Cancer Epidemiol Biomarkers Prev 4(6): 583-588, 1995.
41. Liao M: Some features of lung cancer in China. Lung Cancer 10(1-2): 107-116, 1993.
42. Shaw GL, Mulshine JL: General strategies for early detection: New ideas and future directions. Lung Cancer Principles and Practice 329-349, 1996.
43. Crespi CL, Penman BW, Gelboin HV, Gonzalez FJ: A tobacco smokederived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502DG6. Carcinogenesis 12: 1197, 1991.